AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 38 filers reported holding AN2 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $804,000 | -3.9% | 50,000 | -49.2% | 0.01% | -16.7% |
| Q2 2023 | $836,621 | +75.0% | 98,426 | +103.3% | 0.01% | +50.0% |
| Q1 2023 | $477,965 | +3.6% | 48,426 | 0.0% | 0.00% | -20.0% |
| Q4 2022 | $461,500 | -74.9% | 48,426 | -54.2% | 0.01% | -76.2% |
| Q3 2022 | $1,837,000 | +89.6% | 105,718 | -15.4% | 0.02% | +90.9% |
| Q2 2022 | $969,000 | -48.6% | 125,000 | 0.0% | 0.01% | -47.6% |
| Q1 2022 | $1,884,000 | – | 125,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 233,330 | $4,055,000 | 1.50% |
| RA Capital Management | 3,773,517 | $65,584,000 | 1.40% |
| BVF INC/IL | 1,616,665 | $28,098,000 | 1.16% |
| Avidity Partners Management LP | 742,630 | $12,907,000 | 0.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 716,538 | $12,453,000 | 0.25% |
| Alyeska Investment Group, L.P. | 105,718 | $1,837,000 | 0.02% |
| Woodline Partners LP | 76,145 | $1,323,000 | 0.02% |
| Citadel Advisors | 1,336,983 | $23,237,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 5,726 | $100,000 | 0.00% |
| CITIGROUP INC | 134,545 | $2,338,000 | 0.00% |